Cubist Systematic Strategies LLC bought a new position in Sapiens International Co. (NASDAQ:SPNS - Free Report) during the fourth quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm bought 68,813 shares of the technology company's stock, valued at approximately $1,849,000. Cubist Systematic Strategies LLC owned about 0.12% of Sapiens International as of its most recent SEC filing.
Other large investors have also recently bought and sold shares of the company. Franklin Resources Inc. raised its holdings in shares of Sapiens International by 7.7% during the third quarter. Franklin Resources Inc. now owns 19,540 shares of the technology company's stock valued at $700,000 after buying an additional 1,391 shares during the last quarter. Barclays PLC raised its holdings in shares of Sapiens International by 415.1% during the third quarter. Barclays PLC now owns 54,640 shares of the technology company's stock valued at $2,036,000 after buying an additional 44,033 shares during the last quarter. JPMorgan Chase & Co. raised its holdings in shares of Sapiens International by 22.6% during the third quarter. JPMorgan Chase & Co. now owns 177,878 shares of the technology company's stock valued at $6,630,000 after buying an additional 32,780 shares during the last quarter. MetLife Investment Management LLC raised its holdings in shares of Sapiens International by 7.3% during the fourth quarter. MetLife Investment Management LLC now owns 18,535 shares of the technology company's stock valued at $498,000 after buying an additional 1,263 shares during the last quarter. Finally, Morgan Dempsey Capital Management LLC raised its holdings in shares of Sapiens International by 8.8% during the fourth quarter. Morgan Dempsey Capital Management LLC now owns 6,635 shares of the technology company's stock valued at $178,000 after buying an additional 539 shares during the last quarter. Institutional investors own 30.73% of the company's stock.
Sapiens International Price Performance
Shares of NASDAQ SPNS traded up $0.03 during trading on Friday, hitting $28.54. The company had a trading volume of 120,960 shares, compared to its average volume of 155,475. The company has a market cap of $1.60 billion, a P/E ratio of 22.12 and a beta of 0.95. Sapiens International Co. has a 52 week low of $23.69 and a 52 week high of $41.22. The business's 50-day moving average is $27.10 and its 200 day moving average is $27.63. The company has a debt-to-equity ratio of 0.04, a quick ratio of 2.18 and a current ratio of 2.24.
Sapiens International (NASDAQ:SPNS - Get Free Report) last posted its quarterly earnings results on Thursday, May 8th. The technology company reported $0.37 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.35 by $0.02. The company had revenue of $136.11 million for the quarter, compared to analysts' expectations of $136.25 million. Sapiens International had a return on equity of 17.42% and a net margin of 13.31%. The firm's revenue was up 1.4% on a year-over-year basis. During the same quarter in the prior year, the company earned $0.36 earnings per share. Equities research analysts predict that Sapiens International Co. will post 1.42 earnings per share for the current fiscal year.
Sapiens International Increases Dividend
The company also recently disclosed a semi-annual dividend, which was paid on Wednesday, April 16th. Shareholders of record on Monday, April 7th were given a dividend of $0.66 per share. This represents a yield of 2.2%. This is a boost from Sapiens International's previous semi-annual dividend of $0.22. The ex-dividend date of this dividend was Monday, April 7th. Sapiens International's payout ratio is presently 46.15%.
Analyst Upgrades and Downgrades
SPNS has been the topic of a number of recent analyst reports. Needham & Company LLC reaffirmed a "buy" rating and set a $35.00 price target on shares of Sapiens International in a report on Wednesday, February 19th. Barclays boosted their target price on Sapiens International from $28.00 to $31.00 and gave the stock an "underweight" rating in a report on Friday, May 9th. Finally, Jefferies Financial Group cut Sapiens International from a "buy" rating to a "hold" rating and dropped their target price for the stock from $36.00 to $28.00 in a report on Monday, February 3rd. One analyst has rated the stock with a sell rating, two have issued a hold rating and three have issued a buy rating to the company. According to data from MarketBeat, the company currently has a consensus rating of "Hold" and a consensus price target of $34.25.
Get Our Latest Stock Report on SPNS
Sapiens International Profile
(
Free Report)
Sapiens International Corporation N.V. provides software solutions for the insurance industry in North America, the United Kingdom, Europe, the Middle East, Africa, the Asia Pacific, and internationally. The company provides various solutions for property and casualty commercial and personal lines, life and pensions, and reinsurance fields.
Further Reading
Before you consider Sapiens International, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Sapiens International wasn't on the list.
While Sapiens International currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Today, we are inviting you to take a free peek at our proprietary, exclusive, and up-to-the-minute list of 20 stocks that Wall Street's top analysts hate.
Many of these appear to have good fundamentals and might seem like okay investments, but something is wrong. Analysts smell something seriously rotten about these companies. These are true "Strong Sell" stocks.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
